-
Je něco špatně v tomto záznamu ?
Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in colorectal cancer
J. Sana, S. Hankeova, M. Svoboda, I. Kiss, R. Vyzula, O. Slaby
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS10352
MZ0
CEP - Centrální evidence projektů
NS9814
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Plný text - Článek
Zdroj
Zdroj
NLK
ProQuest Central
od 1998-01-01 do 2015-11-30
Medline Complete (EBSCOhost)
od 1998-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1998-01-01 do 2015-11-30
Health & Medicine (ProQuest)
od 1998-01-01 do 2015-11-30
Family Health Database (ProQuest)
od 1998-01-01 do 2015-11-30
Public Health Database (ProQuest)
od 1998-01-01 do 2015-11-30
PubMed
22328099
DOI
10.1159/000336479
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- kolorektální nádory genetika mortalita patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádorové biomarkery analýza MeSH
- nekódující RNA analýza MeSH
- retrospektivní studie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: The development of colorectal cancer (CRC) is characterized by multiple genetic alterations. Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in human leukemia and carcinoma. METHODS: In our study, we examined the expression levels of uc.43, uc.73, uc.134, uc.230, uc.339, uc.388 and uc.399 in 54 samples of primary colorectal carcinomas and 15 samples of non-tumoral adjacent tissues by real-time PCR. T-UCR expression levels were also correlated with commonly used clinicopathological features of CRC. RESULTS: Expression levels of uc.73 (p = 0.0139) and uc.388 (p = 0.0325) were significantly decreased in CRC tissue, and uc.73 indicated a positive correlation with overall survival (p = 0.0315). The lower expression of uc.388 was associated with the distal location of CRC (p = 0.0183), but no correlation of any evaluated T-UCR with clinical stage, grade and tumor diameter was observed. CONCLUSION: Our preliminary results suggest that uc.73 and uc.388 could be potential diagnostic and prognostic biomarkers in CRC patients.
Central European Institute of Technology Masaryk University Brno Czech Republic
Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024032
- 003
- CZ-PrNML
- 005
- 20141215125441.0
- 007
- ta
- 008
- 120815e20120211sz f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1159/000336479 $2 doi
- 035 __
- $a (PubMed)22328099
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Sana, J. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 245 10
- $a Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in colorectal cancer / $c J. Sana, S. Hankeova, M. Svoboda, I. Kiss, R. Vyzula, O. Slaby
- 520 9_
- $a OBJECTIVES: The development of colorectal cancer (CRC) is characterized by multiple genetic alterations. Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in human leukemia and carcinoma. METHODS: In our study, we examined the expression levels of uc.43, uc.73, uc.134, uc.230, uc.339, uc.388 and uc.399 in 54 samples of primary colorectal carcinomas and 15 samples of non-tumoral adjacent tissues by real-time PCR. T-UCR expression levels were also correlated with commonly used clinicopathological features of CRC. RESULTS: Expression levels of uc.73 (p = 0.0139) and uc.388 (p = 0.0325) were significantly decreased in CRC tissue, and uc.73 indicated a positive correlation with overall survival (p = 0.0315). The lower expression of uc.388 was associated with the distal location of CRC (p = 0.0183), but no correlation of any evaluated T-UCR with clinical stage, grade and tumor diameter was observed. CONCLUSION: Our preliminary results suggest that uc.73 and uc.388 could be potential diagnostic and prognostic biomarkers in CRC patients.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a kolorektální nádory $x genetika $x mortalita $x patologie $7 D015179
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nekódující RNA $x analýza $7 D022661
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a nádorové biomarkery $x analýza $7 D014408
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hankeova, S. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Svoboda, M. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Kiss, I. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Vyzula, R. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Slaby, O. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00003601 $t Oncology $x 1423-0232 $g Roč. 82, č. 2 (20120211), s. 114-118
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22328099 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20141215125540 $b ABA008
- 999 __
- $a ok $b bmc $g 946180 $s 781360
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 82 $c 2 $d 114-118 $e 20120211 $i 1423-0232 $m Oncology $n Oncology $x MED00003601
- GRA __
- $a NS10352 $p MZ0
- GRA __
- $a NS9814 $p MZ0
- LZP __
- $a Pubmed-20120815/12/02